Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

<p>Why targeting the microbiome is not so successful: can randomness overcome the adaptation that occurs following gut manipulation?</p>
Yaron Ilan
Clinical and Experimental Gastroenterology (2019) Vol. Volume 12, pp. 209-217
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Correlation and association analyses in microbiome study integrating multiomics in health and disease
Yinglin Xia
Progress in molecular biology and translational science (2020), pp. 309-491
Closed Access | Times Cited: 165
Establishing a second-generation artificial intelligence-based system for improving diagnosis, treatment, and monitoring of patients with rare diseases
Noa Hurvitz, Henny Azmanov, Asa Kesler, et al.
European Journal of Human Genetics (2021) Vol. 29, Iss. 10, pp. 1485-1490
Open Access | Times Cited: 63
Emerging role of the cGAS-STING signaling pathway in autoimmune diseases: Biologic function, mechanisms and clinical prospection
Ying Hu, Bangjie Chen, Fan Yang, et al.
Autoimmunity Reviews (2022) Vol. 21, Iss. 9, pp. 103155-103155
Closed Access | Times Cited: 51
Using chronobiology-based second-generation artificial intelligence digital system for overcoming antimicrobial drug resistance in chronic infections
Yotam Kolben, Henny Azmanov, Ram Gelman, et al.
Annals of Medicine (2023) Vol. 55, Iss. 1, pp. 311-318
Open Access | Times Cited: 24
Bacteriophages, gut bacteria, and microbial pathways interplay in cardiometabolic health
Daniel Kirk, Ricardo Costeira, Alessia Visconti, et al.
Cell Reports (2024) Vol. 43, Iss. 2, pp. 113728-113728
Open Access | Times Cited: 8
Introducing Patterns of Variability for Overcoming Compensatory Adaptation of the Immune System to Immunomodulatory Agents: A Novel Method for Improving Clinical Response to Anti-TNF Therapies
Tawfik Khoury, Yaron Ilan
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 61
A Personalized Signature and Chronotherapy-Based Platform for Improving the Efficacy of Sepsis Treatment
Ariel Kenig, Yaron Ilan
Frontiers in Physiology (2019) Vol. 10
Open Access | Times Cited: 55
Introducing variability in targeting the microtubules: Review of current mechanisms and future directions in colchicine therapy
Esther Forkosh, Ariel Kenig, Yaron Ilan
Pharmacology Research & Perspectives (2020) Vol. 8, Iss. 4
Open Access | Times Cited: 54
Order Through Disorder: The Characteristic Variability of Systems
Yaron Ilan
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 53
Adropin as a potential mediator of the metabolic system‐autonomic nervous system‐chronobiology axis: Implementing a personalized signature‐based platform for chronotherapy
Yotam Kolben, Sarah Weksler‐Zangen, Yaron Ilan
Obesity Reviews (2020) Vol. 22, Iss. 2
Closed Access | Times Cited: 52
Improving Global Healthcare and Reducing Costs Using Second-Generation Artificial Intelligence-Based Digital Pills: A Market Disruptor
Yaron Ilan
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 2, pp. 811-811
Open Access | Times Cited: 49
A Subject-Tailored Variability-Based Platform for Overcoming the Plateau Effect in Sports Training: A Narrative Review
Ram Gelman, Marc Berg, Yaron Ilan
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 3, pp. 1722-1722
Open Access | Times Cited: 36
Next-Generation Personalized Medicine: Implementation of Variability Patterns for Overcoming Drug Resistance in Chronic Diseases
Yaron Ilan
Journal of Personalized Medicine (2022) Vol. 12, Iss. 8, pp. 1303-1303
Open Access | Times Cited: 33
Microtubules as a potential platform for energy transfer in biological systems: a target for implementing individualized, dynamic variability patterns to improve organ function
Yaron Ilan
Molecular and Cellular Biochemistry (2022) Vol. 478, Iss. 2, pp. 375-392
Closed Access | Times Cited: 29
The role of bacterial translocation in sepsis: a new target for therapy
Assaf Potruch, Asaf Schwartz, Yaron Ilan
Therapeutic Advances in Gastroenterology (2022) Vol. 15
Open Access | Times Cited: 28
Making use of noise in biological systems
Yaron Ilan
Progress in Biophysics and Molecular Biology (2023) Vol. 178, pp. 83-90
Closed Access | Times Cited: 21
A second-generation artificial intelligence-based therapeutic regimen improves diuretic resistance in heart failure: Results of a feasibility open-labeled clinical trial
Ram Gelman, Noa Hurvitz, Rima Nesserat, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114334-114334
Open Access | Times Cited: 19
Overcoming Low Adherence to Chronic Medications by Improving their Effectiveness Using a Personalized Second-generation Digital System
Areej Bayatra, Rima Nasserat, Yaron Ilan
Current Pharmaceutical Biotechnology (2024) Vol. 25, Iss. 16, pp. 2078-2088
Closed Access | Times Cited: 5
Advanced Tailored Randomness: A Novel Approach for Improving the Efficacy of Biological Systems
Yaron Ilan
Journal of Computational Biology (2019) Vol. 27, Iss. 1, pp. 20-29
Open Access | Times Cited: 48
The role of chronobiology in drug-resistance epilepsy: The potential use of a variability and chronotherapy-based individualized platform for improving the response to anti-seizure drugs
Assaf Potruch, Salim T. Khoury, Yaron Ilan
Seizure (2020) Vol. 80, pp. 201-211
Open Access | Times Cited: 48
Personalized inherent randomness of the immune system is manifested by an individualized response to immune triggers and immunomodulatory therapies: a novel platform for designing personalized immunotherapies
Madi El-Haj, Dimitri Kanovitch, Yaron Ilan
Immunologic Research (2019) Vol. 67, Iss. 4-5, pp. 337-347
Closed Access | Times Cited: 47
Overcoming Compensatory Mechanisms toward Chronic Drug Administration to Ensure Long-Term, Sustainable Beneficial Effects
Yaron Ilan
Molecular Therapy — Methods & Clinical Development (2020) Vol. 18, pp. 335-344
Open Access | Times Cited: 46
Overcoming randomness does not rule out the importance of inherent randomness for functionality
Yaron Ilan
Journal of Biosciences (2019) Vol. 44, Iss. 6
Closed Access | Times Cited: 44
Second-Generation Digital Health Platforms: Placing the Patient at the Center and Focusing on Clinical Outcomes
Yaron Ilan
Frontiers in Digital Health (2020) Vol. 2
Open Access | Times Cited: 44
Role of the Immune System and the Circadian Rhythm in the Pathogenesis of Chronic Pancreatitis
Asa Kessler, Sarah Weksler‐Zangen, Yaron Ilan
Pancreas (2020) Vol. 49, Iss. 8, pp. 1024-1032
Closed Access | Times Cited: 42
Page 1 - Next Page

Scroll to top